Evotec SE (EVO) Dividends Paid - Common (2009 - 2026)
Evotec SE (EVO) posted Dividends Paid - Common of $454146.3 for Q1 2026, up 538.69% sequentially from -$103523.3 in Q3 2025, and up 51.29% YoY from $300183.6 in Q1 2025.
Evotec SE (EVO) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Evotec SE has reported Dividends Paid - Common for 8 years, with the latest figure at $454146.3 in Q1 2026.
- Quarterly Dividends Paid - Common rose 51.29% year-over-year to $454146.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $630938.4 (up 13.99% YoY) and the FY2009 annual result came in at $45.9 million, changed N/A from the prior year.
- Dividends Paid - Common climbed to $454146.3 in Q1 2026 per EVO's latest filing, from -$103523.3 in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $741290.6 in Q1 2022 and troughed at -$235007.6 in Q3 2022.
- A 5-year average of $151295.2 and a median of $43123.4 in 2023 frame the typical range for Dividends Paid - Common.
- The sharpest annual moves came in 2022 and 2025: Dividends Paid - Common surged 267.71% in 2022, then tumbled 1101.22% in 2025.
- Over 5 years, Dividends Paid - Common stood at -$235007.6 in 2022, then jumped by 118.35% to $43123.4 in 2023, then tumbled by 76.02% to $10339.7 in 2024, then tumbled by 1101.22% to -$103523.3 in 2025, then jumped by 538.69% to $454146.3 in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $454146.3, -$103523.3, and -$19868.2 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 223.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -941.91 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 139.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - | 454,146.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 454,146.29 |
| Mar 31, 2026 | 454,146.29 |
| Sep 30, 2025 | -103,523.34 |
| Sep 30, 2025 | -103,523.34 |
| Jun 30, 2025 | -19,868.16 |
| Jun 30, 2025 | -19,868.16 |
| Mar 31, 2025 | 300,183.63 |
| Mar 31, 2025 | 300,183.63 |
| Sep 30, 2024 | 10,339.74 |
| Sep 30, 2024 | 10,339.74 |
| Jun 30, 2024 | -222,299.75 |
| Jun 30, 2024 | -222,299.75 |
| Mar 31, 2024 | 465,300.69 |
| Mar 31, 2024 | 465,300.69 |
| Sep 30, 2023 | 43,123.42 |
| Sep 30, 2023 | 43,123.42 |
| Jun 30, 2023 | 50,993.24 |
| Jun 30, 2023 | 50,993.24 |
| Mar 31, 2023 | 443,207.52 |
| Mar 31, 2023 | 443,207.52 |